ATE417106T1 - Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon - Google Patents
Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davonInfo
- Publication number
- ATE417106T1 ATE417106T1 AT00908862T AT00908862T ATE417106T1 AT E417106 T1 ATE417106 T1 AT E417106T1 AT 00908862 T AT00908862 T AT 00908862T AT 00908862 T AT00908862 T AT 00908862T AT E417106 T1 ATE417106 T1 AT E417106T1
- Authority
- AT
- Austria
- Prior art keywords
- dna fragments
- chlamydia
- corresponding dna
- strain
- host
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12396699P | 1999-03-12 | 1999-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE417106T1 true ATE417106T1 (de) | 2008-12-15 |
Family
ID=22411985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00908862T ATE417106T1 (de) | 1999-03-12 | 2000-03-09 | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon |
Country Status (10)
Country | Link |
---|---|
US (3) | US7183402B2 (de) |
EP (2) | EP1163342B1 (de) |
JP (1) | JP4832646B2 (de) |
AT (1) | ATE417106T1 (de) |
AU (1) | AU775695B2 (de) |
CA (1) | CA2365196C (de) |
DE (1) | DE60041042D1 (de) |
MX (1) | MXPA01009256A (de) |
NZ (1) | NZ514140A (de) |
WO (1) | WO2000055326A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
DE69930147T2 (de) * | 1998-12-04 | 2007-01-11 | University Of Manitoba, Winnipeg | Zwei-schritte-verfahren zur impfung gegen chlamydia |
US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
WO2001036456A2 (en) * | 1999-11-15 | 2001-05-25 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
NZ520200A (en) * | 1999-12-22 | 2004-04-30 | Aventis Pasteur | Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product |
GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
KR101866301B1 (ko) * | 2010-03-29 | 2018-06-11 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 하나 이상의 cxxc 모티프를 포함하는 폴리펩티드 및 이종 항원을 포함하는 약학 조성물 및 이의 용도 |
KR101397776B1 (ko) * | 2010-04-02 | 2014-05-20 | 니혼도꾸슈도교 가부시키가이샤 | 스파크 플러그 |
US10835601B2 (en) | 2015-11-10 | 2020-11-17 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
US11185555B2 (en) | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879213A (en) * | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5776746A (en) * | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
US6210876B1 (en) * | 1996-06-06 | 2001-04-03 | Abbott Laboratories | Nucleic acid primers and probes for detecting Chlamydia pneumoniae |
US20020044949A1 (en) * | 1997-04-01 | 2002-04-18 | Harold Kleanthous | 76 kda helicobacter polypeptides and corresponding polynucleotide molecules |
US6020191A (en) * | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
BR9810288A (pt) * | 1997-06-23 | 2000-09-19 | Loke Diagnostics Aps | Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. |
CA2307846A1 (en) | 1997-11-21 | 1999-06-03 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
ES2352082T3 (es) * | 1997-11-21 | 2011-02-15 | Merck Serono Biodevelopment | Polipéptido de la membrana externa de chlamydia pneumoniae, fragmentos del mismo y sus usos, en particular para el diagnóstico, la prevención y el tratamiento de una infección polipéptido de la membrana externa de chlamydia pneumoniae, fragmentos del mismo y sus usos, en particular para el diagnóstico, la prevención y el tratamiento de una infección. |
EP2218731A1 (de) | 1997-11-28 | 2010-08-18 | Merck Serono Biodevelopment | Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion |
US6693087B1 (en) | 1998-08-20 | 2004-02-17 | Aventis Pasteur Limited | Nucleic acid molecules encoding POMP91A protein of Chlamydia |
CA2340330A1 (en) | 1998-08-20 | 2000-03-02 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein c of chlamydia |
JP2002525078A (ja) * | 1998-09-15 | 2002-08-13 | イェール ユニバーシティ | 人工的長末端反復配列 |
MXPA01004291A (es) | 1998-10-28 | 2003-06-09 | Aventis Pasteur | Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos. |
US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
JP2002529069A (ja) | 1998-11-12 | 2002-09-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | クラミジア・ニューモニエのゲノム配列 |
JP2002531093A (ja) | 1998-12-01 | 2002-09-24 | アベンティス、パストゥール、リミテッド | クラミジア抗原および対応するdna断片ならびにその使用 |
US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
EP1144642B1 (de) | 1998-12-08 | 2010-05-26 | Corixa Corporation | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
WO2000066739A2 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
NZ517952A (en) | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
EP1255783B1 (de) * | 1999-12-15 | 2005-12-07 | Univation Technologies LLC | Polymerisationsverfahren |
AU2138501A (en) | 1999-12-22 | 2001-07-03 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
NZ520200A (en) | 1999-12-22 | 2004-04-30 | Aventis Pasteur | Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product |
JP4737909B2 (ja) * | 2000-04-03 | 2011-08-03 | 三菱鉛筆株式会社 | 油性ボールペンインキ組成物及び油性ボールペン |
US20020071831A1 (en) | 2000-04-04 | 2002-06-13 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US20020132994A1 (en) | 2000-04-04 | 2002-09-19 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US20020094965A1 (en) * | 2000-04-04 | 2002-07-18 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US20030100706A1 (en) | 2000-04-04 | 2003-05-29 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US20020082402A1 (en) | 2000-04-04 | 2002-06-27 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
EP1278855B1 (de) | 2000-04-21 | 2008-03-12 | Corixa Corporation | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
US20040254130A1 (en) | 2000-05-08 | 2004-12-16 | Murdin Andrew D | Chlamydia antigens and corresponding dna fragments and uses thereof |
EP1282718B1 (de) | 2000-05-08 | 2006-12-20 | Sanofi Pasteur Limited | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
ATE440861T1 (de) | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
US6706274B2 (en) | 2001-01-18 | 2004-03-16 | Scimed Life Systems, Inc. | Differential delivery of nitric oxide |
US7061245B2 (en) * | 2004-02-06 | 2006-06-13 | Snap-On Incorporated | Coil-on plug capacitive sensors and passive coil-on plug diagnostic system incorporating same |
-
2000
- 2000-03-09 EP EP00908862A patent/EP1163342B1/de not_active Expired - Lifetime
- 2000-03-09 EP EP08004636A patent/EP2172214A3/de not_active Withdrawn
- 2000-03-09 DE DE60041042T patent/DE60041042D1/de not_active Expired - Lifetime
- 2000-03-09 NZ NZ514140A patent/NZ514140A/en not_active IP Right Cessation
- 2000-03-09 JP JP2000605744A patent/JP4832646B2/ja not_active Expired - Fee Related
- 2000-03-09 AT AT00908862T patent/ATE417106T1/de active
- 2000-03-09 MX MXPA01009256A patent/MXPA01009256A/es unknown
- 2000-03-09 AU AU31383/00A patent/AU775695B2/en not_active Ceased
- 2000-03-09 WO PCT/CA2000/000240 patent/WO2000055326A1/en active IP Right Grant
- 2000-03-09 CA CA2365196A patent/CA2365196C/en not_active Expired - Fee Related
-
2004
- 2004-11-01 US US10/976,917 patent/US7183402B2/en not_active Expired - Fee Related
-
2005
- 2005-04-18 US US11/107,823 patent/US7285276B2/en not_active Expired - Fee Related
-
2007
- 2007-09-11 US US11/898,220 patent/US7629327B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7629327B2 (en) | 2009-12-08 |
MXPA01009256A (es) | 2003-07-14 |
AU775695B2 (en) | 2004-08-12 |
NZ514140A (en) | 2001-09-28 |
JP4832646B2 (ja) | 2011-12-07 |
CA2365196C (en) | 2011-11-15 |
WO2000055326A1 (en) | 2000-09-21 |
US20050186266A1 (en) | 2005-08-25 |
US7285276B2 (en) | 2007-10-23 |
CA2365196A1 (en) | 2000-09-21 |
EP1163342B1 (de) | 2008-12-10 |
JP2002538825A (ja) | 2002-11-19 |
US7183402B2 (en) | 2007-02-27 |
EP2172214A2 (de) | 2010-04-07 |
EP1163342A1 (de) | 2001-12-19 |
US20080113933A1 (en) | 2008-05-15 |
AU3138300A (en) | 2000-10-04 |
EP2172214A3 (de) | 2011-03-16 |
DE60041042D1 (de) | 2009-01-22 |
US20050069942A1 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
ATE384793T1 (de) | Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen | |
ATE342917T1 (de) | Antimikrobielle polypeptide aus pseudoplectania nigrella | |
ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
PT1219711E (pt) | Vacina de lawsonia intracellularis | |
ATE284898T1 (de) | Synthetische papillomavirus gene, welche für expression in menschlichen zellen optimiert sind | |
WO2002018595A3 (en) | Moraxella polypeptides and corresponding dna fragments and uses thereof | |
ATE417106T1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
RS92704A (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
JP2004528803A5 (de) | ||
WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2005026200A3 (en) | Lawsonia intracellularis subunit vaccine | |
DK1274853T3 (da) | Materialer og fremgangsmåder, der angår immunreaktioner på fusionsproteiner | |
MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
WO2000026239A3 (en) | $i(chlamydia) antigens and corresponding dna fragments and uses thereof | |
WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2000011183A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
DE69925927D1 (de) | Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1163342 Country of ref document: EP |